96 related articles for article (PubMed ID: 18413256)
1. Biochemical and biological characterization of tumor-associated mutations of p110alpha.
Denley A; Gymnopoulos M; Hart JR; Jiang H; Zhao L; Vogt PK
Methods Enzymol; 2008; 438():291-305. PubMed ID: 18413256
[TBL] [Abstract][Full Text] [Related]
2. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.
Avruch J; Hara K; Lin Y; Liu M; Long X; Ortiz-Vega S; Yonezawa K
Oncogene; 2006 Oct; 25(48):6361-72. PubMed ID: 17041622
[TBL] [Abstract][Full Text] [Related]
3. Rheb activation of mTOR and S6K1 signaling.
Hanrahan J; Blenis J
Methods Enzymol; 2006; 407():542-55. PubMed ID: 16757352
[TBL] [Abstract][Full Text] [Related]
4. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.
Fingar DC; Blenis J
Oncogene; 2004 Apr; 23(18):3151-71. PubMed ID: 15094765
[TBL] [Abstract][Full Text] [Related]
5. Rheb promotes cell growth as a component of the insulin/TOR signalling network.
Saucedo LJ; Gao X; Chiarelli DA; Li L; Pan D; Edgar BA
Nat Cell Biol; 2003 Jun; 5(6):566-71. PubMed ID: 12766776
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
[TBL] [Abstract][Full Text] [Related]
7. Novel role of the small GTPase Rheb: its implication in endocytic pathway independent of the activation of mammalian target of rapamycin.
Saito K; Araki Y; Kontani K; Nishina H; Katada T
J Biochem; 2005 Mar; 137(3):423-30. PubMed ID: 15809346
[TBL] [Abstract][Full Text] [Related]
8. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.
Lim KH; Counter CM
Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase: from viral oncoprotein to drug target.
Vogt PK; Bader AG; Kang S
Virology; 2006 Jan; 344(1):131-8. PubMed ID: 16364744
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
[TBL] [Abstract][Full Text] [Related]
11. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila.
Stocker H; Radimerski T; Schindelholz B; Wittwer F; Belawat P; Daram P; Breuer S; Thomas G; Hafen E
Nat Cell Biol; 2003 Jun; 5(6):559-65. PubMed ID: 12766775
[TBL] [Abstract][Full Text] [Related]
12. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
[TBL] [Abstract][Full Text] [Related]
13. Increased Rheb-TOR signaling enhances sensitivity of the whole organism to oxidative stress.
Patel PH; Tamanoi F
J Cell Sci; 2006 Oct; 119(Pt 20):4285-92. PubMed ID: 17038544
[TBL] [Abstract][Full Text] [Related]
14. Functional inhibition of PI3K by the betaGBP molecule suppresses Ras-MAPK signalling to block cell proliferation.
Wells V; Downward J; Mallucci L
Oncogene; 2007 Dec; 26(55):7709-14. PubMed ID: 17603562
[TBL] [Abstract][Full Text] [Related]
15. Cancer-specific mutations in phosphatidylinositol 3-kinase.
Vogt PK; Kang S; Elsliger MA; Gymnopoulos M
Trends Biochem Sci; 2007 Jul; 32(7):342-9. PubMed ID: 17561399
[TBL] [Abstract][Full Text] [Related]
16. Constitutively active Rheb induces oncogenic transformation.
Jiang H; Vogt PK
Oncogene; 2008 Sep; 27(43):5729-40. PubMed ID: 18521078
[TBL] [Abstract][Full Text] [Related]
17. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
Geering B; Cutillas PR; Vanhaesebroeck B
Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
19. PI3 kinases in cancer: from oncogene artifact to leading cancer target.
Zhao JJ; Roberts TM
Sci STKE; 2006 Dec; 2006(365):pe52. PubMed ID: 17164467
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the small GTPase Rheb by amino acids.
Roccio M; Bos JL; Zwartkruis FJ
Oncogene; 2006 Feb; 25(5):657-64. PubMed ID: 16170341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
